Horizon Therapeutics Public Limited Company

Ticker

HZNP

ISIN

IE00BQPVQZ6

Price

-

Change Today

-

Price 1 year ago

-

Market Capitalization

15,952,320,512.00


Price evolution

Yearly Returns


Peers


Peers

Company information

Summary

Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion; KRYSTEXXA (pegloticase injection) for intravenous infusion; RAVICTI (glycerol phenylbutyrate) oral liquid; PROCYSBI (cysteamine bitartrate) delayed-release capsules and granules for oral use; ACTIMMUNE (interferon gamma-1b) injection for subcutaneous use; BUPHENYL (sodium phenylbutyrate) tablets and powder for oral use; QUINSAIR (levofloxacin) solution for inhalation; and UPLIZNA (inebilizumab-cdon) injection for intravenous use. The company also markets PENNSAID (diclofenac sodium topical solution) for topical use; DUEXIS (ibuprofen/famotidine) tablets for oral use; RAYOS (prednisone) delayed-release tablets for oral use; and VIMOVO (naproxen/esomeprazole magnesium) delayed-release tablets for oral use. It has collaboration agreements with HemoShear Therapeutics, LLC.; Alpine Immune Sciences, Inc.; Halozyme Therapeutics, Inc.; and Arrowhead Pharmaceuticals, Inc. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland with additional offices in Deerfield, Illinois; Chicago, Illinois; Lake Forest, Illinois; South San Francisco, California; Washington, D.C.; Gaithersburg, Maryland; Rockville, Maryland; and Mannheim, Germany.

Sector

Healthcare

Industry

Drug Manufacturers—General

Country

Ireland

Exchange

NMS

Earnings Per Share

1.81

P/E Ratio

38.856358

Debt/Equity Ratio

55.731

Beta

1.156662

City

Dublin

Address

70 St. Stephen’s Green

Zip

2

Ebitda

973,361,024.00

Ebitda Margins

0.26

Enterprise to Ebitda

20.67

Enterprise Value

20,115,394,560.00

Target Price

-

Estimated Price

-

Book Value

18.19

Expected Growth

-

Balance sheet

Income statement

Sustainability

Correlation

Company Name Correlation
4568.T DAIICHI SANKYO COMPANY LIMITED -0.17
KLBF.JK Kalbe Farma Tbk. -0.07
600276.SS JIANGSU HENGRUI MEDICAL CO LTD -0.04
600436.SS ZHANGZHOU PIENTZEHUANG PHARMACE 0.06
MYX.AX M PHARMA FPO 0.06
600771.SS GUANGYUYUAN CHINESE HERBAL MEDI 0.09
300006.SZ CHONGQING LUMMY PH 0.16
600713.SS NANJING PHARMACEUTICAL CO LTD 0.16
4503.T ASTELLAS PHARMA 0.17
LLY Eli Lilly and Company 0.21
NOVN.SW NOVARTIS N 0.21
PFE Pfizer, Inc. 0.22
600867.SS TONGHUA DONGBAO MEDICINES CO LT 0.22
GILD Gilead Sciences, Inc. 0.22
AMGN Amgen Inc. 0.23
4519.T CHUGAI PHARMACEUTICAL CO 0.26
BMY Bristol-Myers Squibb Company 0.27
GSK.L GSK PLC 0.29
ABBV AbbVie Inc. 0.30
SNY Sanofi 0.30
JNJ Johnson & Johnson 0.34
600572.SS ZHEJIANG CONBA PHARMACEUTICAL C 0.36
1093.HK CSPC PHARMA 0.37
GSK GSK plc 0.38
MRK Merck & Company, Inc. 0.39
ECILC.IS ECZACIBASI ILAC 0.48
AZN Astrazeneca PLC 0.57
600613.SS SHANGHAI SHENQI PHARM INVEST MA 0.63
2186.HK LUYE PHARMA 0.64

Similar companies

Ticker Name City Country Currency Exchange Beta EV/EBITDA Employees Site
600276.SS JIANGSU HENGRUI MEDICAL CO LTD Lianyungang China CNY SHH 58.73 24491 https://www.hrs.com.cn
KLBF.JK Kalbe Farma Tbk. Jakarta Indonesia IDR JKT 0.50 14.50 12392 https://www.kalbe.co.id
1093.HK CSPC PHARMA Shijiazhuang China HKD HKG 0.67 12.86 24746 https://www.cspc.com.hk
300006.SZ CHONGQING LUMMY PH Chongqing China CNY SHZ 0.83 -32.33 935 https://www.cqlummy.com
PFE Pfizer, Inc. New York United States USD NYQ 0.68 6.88 79000 https://www.pfizer.com
600572.SS ZHEJIANG CONBA PHARMACEUTICAL C Hangzhou China CNY SHH 0.46 10.69 8589 https://www.conbagroup.com
600713.SS NANJING PHARMACEUTICAL CO LTD Nanjing China CNY SHH 0.46 9.37 5062 https://www.njyy.com
600867.SS TONGHUA DONGBAO MEDICINES CO LT Tonghua China CNY SHH 0.24 12.42 https://www.thdb.com
ECILC.IS ECZACIBASI ILAC Istanbul Turkey TRY IST 0.20 71.70 336 https://www.eczacibasi.com.tr/en/eczacibasi-gruop/companies/other-products-and-services
GSK.L GSK PLC Brentford United Kingdom GBp LSE 0.32 6.22 90096 https://www.gsk.com
MRK Merck & Company, Inc. Kenilworth United States USD NYQ 0.36 10.37 67000 https://www.merck.com
BMY Bristol-Myers Squibb Company New York United States USD NYQ 0.44 8.87 32200 https://www.bms.com
600771.SS GUANGYUYUAN CHINESE HERBAL MEDI Xi'an China CNY SHH 0.55 -48.11 1900 https://www.guangyuyuan.com
GILD Gilead Sciences, Inc. Foster City United States USD NMS 0.39 7.19 14400 https://www.gilead.com
JNJ Johnson & Johnson New Brunswick United States USD NYQ 0.57 14.45 141700 https://www.jnj.com
GSK GSK plc Brentford United Kingdom USD NYQ 0.18 8.08 90096 https://www.gsk.com
AZN Astrazeneca PLC Cambridge United Kingdom USD NMS 0.12 18.55 83100 https://www.astrazeneca.com
ABBV AbbVie Inc. North Chicago United States USD NYQ 0.75 11.46 50000 https://www.abbvie.com
2186.HK LUYE PHARMA Yantai China HKD HKG 0.75 14.06 4845 https://www.luye.cn
600613.SS SHANGHAI SHENQI PHARM INVEST MA Shanghai China CNY SHH 0.36 22.96 1371 https://www.gzsq.com
MYX.AX M PHARMA FPO Salisbury South Australia AUD ASX 1.09 27.98 https://www.maynepharma.com
4568.T DAIICHI SANKYO COMPANY LIMITED Tokyo Japan JPY JPX 52.12 16458 https://www.daiichisankyo.com
4503.T ASTELLAS PHARMA Tokyo Japan JPY JPX 0.58 12.39 14522 https://www.astellas.com
NOVN.SW NOVARTIS N Basel Switzerland CHF EBS 0.50 10.30 108000 https://www.novartis.com
SNY Sanofi Paris France USD NMS 0.36 9.75 95442 https://www.sanofi.com
HZNP Horizon Therapeutics Public Lim Dublin Ireland USD NMS 1.16 20.67 1940 https://www.horizontherapeutics.com
LLY Eli Lilly and Company Indianapolis United States USD NYQ 0.37 29.00 35000 https://www.lilly.com
AMGN Amgen Inc. Thousand Oaks United States USD NMS 0.58 12.61 24200 https://www.amgen.com
4519.T CHUGAI PHARMACEUTICAL CO Tokyo Japan JPY JPX 0.64 9.60 7664 https://www.chugai-pharm.co.jp
600436.SS ZHANGZHOU PIENTZEHUANG PHARMACE Zhangzhou China CNY SHH 0.78 57.53 2591 https://www.zzpzh.com.cn
BAYN.DE BAYER AG Leverkusen Germany EUR GER 1.16 13.66 101914 https://www.bayer.com
AZN.L ASTRAZENECA PLC ORD SHS $0.25 Cambridge United Kingdom GBp LSE 0.10 15.96 83100 https://www.astrazeneca.com
300357.SZ ZHEJIANG WOLWO BIO Huzhou China CNY SHZ 0.40 56.57 1488 https://www.wolwobiotech.com
SAN.PA SANOFI Paris France EUR PAR 0.36 9.86 95442 https://www.sanofi.com
NVS Novartis AG Basel Switzerland USD NYQ 0.49 10.62 108000 https://www.novartis.com
0P6S.IL BAYER AG Leverkusen Germany EUR IOB 1.15 9.51 100753 https://www.bayer.com
CIPLA.NS CIPLA LTD Mumbai India INR NSI 17.91 https://www.cipla.com
4528.T ONO PHARMACEUTICAL CO Osaka Japan JPY JPX 0.33 13.40 3687 https://www.ono-pharma.com
4536.T SANTEN PHARMACEUTICAL CO Osaka Japan JPY JPX 0.37 7.05 4315 https://www.santen.com
OGN Organon & Co. Jersey City United States USD NYQ 7.83 9300 https://www.organon.com

Funds


Mutual Fund Holders

Social

Dividends

Ratings

News

Earnings

SEC Filings

Options

Indicators

Glossary
Momentum
A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend.
Inertia
In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend.
Relative Strength Index (RSI)
A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction.
Fibonacci's Weighted Moving Average
A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend.
Williams %R
A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce.
Relative Volatility Index (RVI)
A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk.
Commodity Channel Index (CCI)
A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.